• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

Opinion

Video

Laboratory Monitoring with Oral JAK Inhibitors

Author(s):

Lisa Swanson, MD, FAAD,Linda Stein Gold, MD

Panelists discuss how to implement and maintain appropriate laboratory monitoring protocols when prescribing oral JAK inhibitors, ensuring patient safety through regular assessment of key clinical parameters.

Related Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
4 experts are featured in this series.
2 experts in this video
2 experts in this video
Related Content
Phase 2 Trial of ADX-629 Underway for Treatment of AD
April 10th 2023

Phase 2 Trial of ADX-629 Underway for Treatment of AD

The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology
June 25th 2020

The Cutaneous Connection: Episode 1- Cannabinoid Use in Dermatology

Considering and Improving Patient Quality of Life in Dermatologic Conditions
March 10th 2023

Considering and Improving Patient Quality of Life in Dermatologic Conditions

Spotlighting Women In Dermatology
March 8th 2023

Spotlighting Women In Dermatology

A Potpourri of Complex Medical Terminology
June 17th 2022

A Potpourri of Complex Medical Terminology

Manifestation of COVID-19 in Skin
March 26th 2022

Manifestation of COVID-19 in Skin

© 2025 MJH Life Sciences

All rights reserved.